Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Albumin-Bound Paclitaxel × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 14 Triple Negative Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Lung Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Rectal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Pancreatic Ductal 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Solid Cancer 1 Recurrence 1 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Non-Small-Cell Lung 1 Non-Small Cell Lung Cancer Metastatic 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms 1 Mouth Neoplasms 1 Metastatic Adenocarcinoma of the Pancreas 1 Lip Neoplasms 1

Interventions

pembrolizumab 22 enfortumab vedotin 14 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Nivolumab 9 Gemcitabine 9 avelumab 8 Cisplatin 8 atezolizumab 7 Carboplatin 7 sacituzumab govitecan 5 Docetaxel 5 Ipilimumab 4 durvalumab 3 Paclitaxel 3 lenvatinib 2 erdafitinib 2 dodecyl maltoside 2 cabozantinib 2 Taxes 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡